Deutsche Bank analyst Emmanuel Papadakis initiates coverage on Alvotech (NASDAQ:ALVO) with a Hold rating and announces Price Target of $10.
Eli Lilly Analysts Bump Up Forecasts On Q2 Print: ‘Beyond Mounjaro, Alzheimer’s Franchise Remains A Key Pillar To Future Growth’
Shares of Eli Lilly And Co (NYSE: LLY) Tuesday spiked, after the company reported strong second-quarter results.